GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Intrinsic Value: Projected FCF

Avricore Health (Avricore Health) Intrinsic Value: Projected FCF : $-0.09 (As of Jun. 11, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-11), Avricore Health's Intrinsic Value: Projected FCF is $-0.09. The stock price of Avricore Health is $0.11645. Therefore, Avricore Health's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Avricore Health's Intrinsic Value: Projected FCF or its related term are showing as below:

AVCRF's Price-to-Projected-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.65
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Avricore Health Intrinsic Value: Projected FCF Historical Data

The historical data trend for Avricore Health's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Intrinsic Value: Projected FCF Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.19 -0.10 -0.09 -0.07

Avricore Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.09 -0.11 -0.10 -0.07

Competitive Comparison of Avricore Health's Intrinsic Value: Projected FCF

For the Diagnostics & Research subindustry, Avricore Health's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Price-to-Projected-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Avricore Health's Price-to-Projected-FCF falls into.



Avricore Health Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Avricore Health's Free Cash Flow(6 year avg) = $-1.00.

Avricore Health's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-1.0008+1.497*0.8)/99.666
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (OTCPK:AVCRF) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Avricore Health's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.11645/-0.083582845476307
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Avricore Health's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Health Announces Lifting of Management Cease Trade Order

By Marketwired Marketwired 06-04-2019

Avricore Health Amends Options

By GlobeNewswire GlobeNewswire 09-11-2020

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022